Intuitive Surgical (NASDAQ:ISRG) Price Target Raised to $644.00

Intuitive Surgical (NASDAQ:ISRG) had its target price boosted by HSBC from $595.00 to $644.00 in a report published on Thursday,MarketScreener reports. They currently have a buy rating on the medical equipment provider’s stock.

A number of other brokerages have also recently commented on ISRG. The Goldman Sachs Group reduced their price objective on Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating on the stock in a research note on Wednesday, October 1st. Zacks Research cut Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 20th. Rothschild & Co Redburn boosted their price objective on Intuitive Surgical from $610.00 to $615.00 and gave the stock a “buy” rating in a research note on Thursday. UBS Group set a $600.00 price objective on Intuitive Surgical and gave the stock a “neutral” rating in a research note on Thursday. Finally, Deutsche Bank Aktiengesellschaft restated a “sell” rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $602.32.

Intuitive Surgical Trading Down 0.9%

ISRG stock opened at $546.51 on Thursday. The stock has a 50-day moving average price of $458.09 and a two-hundred day moving average price of $497.29. Intuitive Surgical has a 12-month low of $425.00 and a 12-month high of $616.00. The company has a market cap of $195.91 billion, a PE ratio of 72.29, a price-to-earnings-growth ratio of 5.45 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The firm had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. During the same quarter in the previous year, the business earned $1.84 earnings per share. The firm’s quarterly revenue was up 22.9% compared to the same quarter last year. Equities analysts forecast that Intuitive Surgical will post 6.43 EPS for the current fiscal year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, Director Amy L. Ladd sold 335 shares of the company’s stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $440.69, for a total transaction of $147,631.15. Following the sale, the director owned 739 shares in the company, valued at $325,669.91. This represents a 31.19% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, insider Gary S. Guthart sold 29,360 shares of the company’s stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the sale, the insider owned 19,827 shares in the company, valued at $9,368,059.23. The trade was a 59.69% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 40,724 shares of company stock worth $19,500,332 in the last 90 days. 0.70% of the stock is currently owned by insiders.

Institutional Trading of Intuitive Surgical

Institutional investors and hedge funds have recently bought and sold shares of the company. Norway Savings Bank raised its stake in Intuitive Surgical by 53.4% during the second quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock valued at $1,420,000 after buying an additional 910 shares in the last quarter. IronOak Wealth LLC. bought a new position in shares of Intuitive Surgical during the second quarter valued at approximately $1,099,000. Trust Co. of Oklahoma bought a new position in shares of Intuitive Surgical during the second quarter valued at approximately $363,000. Neville Rodie & Shaw Inc. grew its holdings in shares of Intuitive Surgical by 11.9% during the second quarter. Neville Rodie & Shaw Inc. now owns 10,427 shares of the medical equipment provider’s stock valued at $5,666,000 after purchasing an additional 1,110 shares during the last quarter. Finally, Sax Wealth Advisors LLC grew its holdings in shares of Intuitive Surgical by 218.1% during the second quarter. Sax Wealth Advisors LLC now owns 2,456 shares of the medical equipment provider’s stock valued at $1,334,000 after purchasing an additional 1,684 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.